PULSAR-ICI

· ImmuneSensor Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PULSAR-ICI, covering 2024-12-09 to 2025-10-20. Get the full timeline:

Most recent: Clinical Trial Update: Study of PULSAR-ICI +/- IMSA101 in Patients With Oligometastatic NSCLC and RCC [Phase 2]